The Inaugural Digital Health Coalition Executive Landscape Study
Guest Mark Bard, co-founder of the Digital Health Coalition, discusses some of the key findings from the October 2012 member survey,
Back to the Pharma Digital Future: A Pharma Social Media Pioneer Looks Back &...
A conversation with Alex Butler, Managing Director at The Earthworks and recipient of the first Pharmaguy Social Media Pioneer Award. We look back over the past three years since Alex won his award at the digital pharma landscape to review what has changed, what remains the same, and what may lie ahead.
The Emerging Virtual Medical Conference: Implications for Pharmacos, HCPs, and Patients
Pharmaguy interviews Len Starnes, Digital Healthcare Consultant, about the transformation of medical conferences/congresses from the physical to the virtual and the implications for pharmaceutical companies, healthcare professionals, and patients.
The Patients Included Charter: A Roadmap for Patient-Centric Conferences
Pharmaguy interviews Casey Quinlan, Co-Founder at Patients for Clinical Research, journalist, author, ePatient and patient advocate, about Patients Included: A Charter for Conferences and how the pharmaceutical industry can help ensure more patients are able to attend and participate in patient-relevant healthcare conferences.
Your DTC Ads Stink!
Why DTC Ads are Ineffective and How Innovative Pretesting Techniques Can Improve Them
Overcoming Barriers to Pharma’s Engagement in Social Networks
An ePharma Pioneer Club roundtable discussion on what it's going to take to enable pharmaceutical marketers to engage in social networks without fear of adverse event reporting and other regulatory, corporate, and cultural roadblocks.
Fear & Loathing in Washington, DC: Takeaways from the FDA Public Hearing
Speakers, attendees and ePharma Pioneer Club members discuss the key takeaways of FDA's November 12-13 public hearing on the use of social media by the pharmaceutical industry. What key points were made? What questions were asked by FDA? What are the next steps?
Pharma Crisis Communications in the Fast-Paced Digital World: The J&J/McNeil Case Study
A conversation with Bill Silberg (Principal at Silberg Consulting), Melissa Davies (Social Media Practice Lead at Return on Focus) Michael Parks (Executive Vice President, Vox Medica, Inc.), and invited ePharma Pioneer Club members about
New Media Tracking Technologies: Implications for Online Consumer Privacy
Learn how you can decrease time to market and reduce costs to deploy strategic initiatives
Patient Advocates Take On the FDA: FAMEDS & Genentech Fight for Avastin
A conversation with Terrence Kalley, founder of Freedom of Access to Medicines (FAMEDS), regarding patient advocacy and his organization's fight against FDA's plans to remove the metastatic breast cancer indication for Avastin, a biologic drug produced and marketed by Genentech/Roche.
